Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human APCDD1 Antibody (SAA1831)

Catalog #:   RHK99501 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA
Accession: Q8J025
Overview

Catalog No.

RHK99501

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

DRAPC1, Protein APCDD1, Adenomatosis polyposis coli down-regulated 1 protein, APCDD1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q8J025

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1831

Data Image
References

Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides., PMID:40505327

Vaccination against helminth IL-33 modulators permits immune-mediated parasite ejection., PMID:40378045

A method for the detection and enrichment of endogenous cereblon substrates., PMID:40196695

A novel flow through assay and smartphone application based prototype for point-of-care diagnosis of tuberculosis., PMID:40049786

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens., PMID:39852798

Iridium oxide-modified reference screen-printed electrodes for point-of-care portable electrochemical cortisol detection., PMID:39216420

Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue., PMID:38293125

Characterisation of TcFUT1, a mitochondrial fucosyltransferase from Trypanosoma cruzi., PMID:37652239

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial., PMID:36895286

Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure., PMID:36883593

Co-Culture of Cryopreserved Healthy Sertoli Cells with Testicular Tissue of Non-Obstructive Azoospermia (NOA) Patients in Culture Media Containing Follicle-Stimulating Hormone (FSH)/Testosterone Has No Advantage in Germ Cell Maturation., PMID:36769720

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials., PMID:36294316

A novel gene, Le-Dd10, is involved in fruiting body formation of Lentinula edodes., PMID:36063239

Managing antibody stability: Effects of stressors on Ipilimumab from the commercial formulation to diluted solutions., PMID:35595030

Not all small HER2 positive breast cancers have the same clinical outcome in the North-East of Scotland., PMID:35325763

Bivalent EGFR-Targeting DARPin-MMAE Conjugates., PMID:35269611

Activation of the Innate Immune Checkpoint CLEC5A on Myeloid Cells in the Absence of Danger Signals Modulates Macrophages' Function but Does Not Trigger the Adaptive T Cell Immune Response., PMID:35252461

Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP., PMID:35235182

Activation of regulatory T cells triggers specific changes in glycosylation associated with Siglec-1-dependent inflammatory responses., PMID:35224210

Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy., PMID:34762848

Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study., PMID:34755204

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity., PMID:34268524

Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer., PMID:34194285

Human chorionic gonadotrophin assays to monitor GTD., PMID:34074603

Age and cancer treatment factors influence patient-reported outcomes following therapeutic mammoplasty and contralateral symmetrisation for the treatment of breast cancer., PMID:33875389

Expression in Escherichia coli, purification and kinetic characterization of LAPLm, a Leishmania major M17-aminopeptidase., PMID:33775769

Siglec and anti-Siglec therapies., PMID:33607404

Identifying the Hidden Population: Former Intravenous Drug Users Who Are No Longer in Contact with Services. "Ask a Friend"., PMID:33504077

Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms., PMID:33459343

Scalar nanostructure of the Candida albicans cell wall; a molecular, cellular and ultrastructural analysis and interpretation., PMID:33294751

The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer's disease., PMID:33272326

Targeting N-myristoylation for therapy of B-cell lymphomas., PMID:33093447

Developing Electron Microscopy Tools for Profiling Plasma Lipoproteins Using Methyl Cellulose Embedment, Machine Learning and Immunodetection of Apolipoprotein B and Apolipoprotein(a)., PMID:32887372

Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents., PMID:32793928

Dupilumab for nasal polyposis., PMID:32711789

Inducible Degradation of Target Proteins through a Tractable Affinity-Directed Protein Missile System., PMID:32668203

New insight into the biology of R-loops., PMID:32516653

Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression., PMID:32501471

WIDENING THE BOTTLENECK OF PHOSPHOPROTEOMICS: EVOLVING STRATEGIES FOR PHOSPHOPEPTIDE ENRICHMENT., PMID:32491218

Antibody RING-Mediated Destruction of Endogenous Proteins., PMID:32454028

Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis., PMID:32294982

Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma., PMID:31842413

IgA: Structure, Function, and Developability., PMID:31817406

Progress in Molecularly Imprinted Polymers for Biomedical Applications., PMID:30914017

Feasibility Analysis of Interleukin-13 as a Target for a Therapeutic Vaccine., PMID:30759882

New developments for prevention of type 1 diabetes: a paradigm shift?, PMID:30592679

The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial., PMID:30227890

Anti-interleukin 13 for asthma: stick or twist?, PMID:30078617

Surveying GPCR solubilisation conditions using surface plasmon resonance., PMID:29908863

The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human., PMID:29743203

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human APCDD1 Antibody (SAA1831) [RHK99501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only